STAT+: Pharmalittle: More top hospitals aren’t offering Biogen Alzheimer’s drug; Pfizer may lower Covid pill price in poor countries until supplies rise

Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the Pharmalot campus, where the official mascot awaits a play date and the short person is, once again, sleeping in. As for us, we are engaged in the usual routines of readying our to-do list and brewing cups of stimulation. Our choice today, for those tracking such things, is southern pecan, all the way from New Orleans. Feel free to join us. Remember, no prescription is required, so no need to track rebates. Meanwhile, here are some tidbits. Hope you have a smashing day and, as always, do keep in touch. We appreciate your feedback and suggestions. …

The organization that negotiates supply contracts on behalf of more than 95% of the nation’s academic hospitals estimates its members are ordering just one to five vials of the controversial Biogen (BIIB) Alzheimer’s medicine each…
Click here to view original post